ArticleFrontiers in artificial intelligence2026
Integration of handcrafted and deep-level features to improve skin disease detection.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As per the World Health Organization, skin disorders are some of the most common health issues, constituting a significant source of non-fatal disease burden and greatly affecting both quality of life and healthcare systems. Melanoma skin cancer is the most fatal disease in the world, and nearly 60,000 people died due to melanoma in 2022. Skin disorders affect millions of people globally and pose a serious threat to public health. These disorders can affect the skin's composition, function, and appearance. To detect and predict skin diseases, a comprehensive physical examination, a review of the patient's medical history, and appropriate laboratory testing are required. Noise, blur, uneven illumination, inadequate feature representation, and overlapping features between distinct skin disorders all reduce the efficacy of skin disease identification. The Skin Disease Detection Network (SDNet), a deep convolutional neural network-based two-way feature depiction system for multiclass skin disease identification, is presented in this study. To depict hierarchical features in skin images, the SDNet employs two parallel arms. The first arm uses a 2D CNN in conjunction with pre-processed original images, while the second arm uses a 1D CNN that accepts Gray Level Co-occurrence Matrix features (GLCM), improved Local Binary Pattern (ILBP), and Histogram of Oriented Gradient (HOG) features to depict texture and shape attributes of skin images. The accuracy, recall, precision, and F1-score of SDNet results are evaluated using the DermNet dataset. The proposed SDNet achieves an overall accuracy of 99.1%, a recall of 99.1%, a precision of 98.96%, and an F1-score of 98.95% for the 5-class skin disease detection, demonstrating a notable improvement over the performance of traditional state-of-the-art methods. This study marks a notable step forward in leveraging the reliability of SDNet for precise and efficient skin disease identification through the Explainable Artificial Intelligence (XAI) approach.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.